Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Index- P/E39.11 EPS (ttm)3.64 Insider Own2.54% Shs Outstand98.70M Perf Week4.09%
Market Cap14.32B Forward P/E21.17 EPS next Y6.72 Insider Trans-24.14% Shs Float98.08M Perf Month7.36%
Income369.70M PEG2.17 EPS next Q1.11 Inst Own93.41% Short Float1.86% Perf Quarter7.54%
Sales1.98B P/S7.23 EPS this Y80.36% Inst Trans-1.46% Short Ratio2.15 Perf Half Y28.52%
Book/sh23.72 P/B6.00 EPS next Y50.85% ROA12.68% Short Interest1.83M Perf Year49.35%
Cash/sh12.03 P/C11.83 EPS next 5Y18.00% ROE18.16% 52W Range89.04 - 148.37 Perf YTD7.99%
Dividend Est.- P/FCF23.31 EPS past 5Y62.04% ROI14.01% 52W High-4.10% Beta0.37
Dividend TTM- Quick Ratio2.47 Sales past 5Y34.77% Gross Margin97.09% 52W Low59.80% ATR (14)3.80
Dividend Ex-DateDec 29, 1995 Current Ratio2.52 EPS Y/Y TTM458.67% Oper. Margin23.73% RSI (14)57.07 Volatility2.21% 2.82%
Employees1400 Debt/Eq0.23 Sales Y/Y TTM23.99% Profit Margin18.65% Recom1.66 Target Price159.25
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q153.10% Payout0.00% Rel Volume0.76 Prev Close141.91
Sales Surprise0.57% EPS Surprise-61.75% Sales Q/Q22.57% EarningsMay 01 BMO Avg Volume848.76K Price142.29
SMA202.47% SMA502.78% SMA20014.53% Trades Volume641,937 Change0.27%
Date Action Analyst Rating Change Price Target Change
Apr-24-24Upgrade Wells Fargo Equal Weight → Overweight $140 → $170
Dec-13-23Resumed Citigroup Neutral $127
Dec-12-23Initiated Deutsche Bank Buy $136
Oct-24-23Resumed Cantor Fitzgerald Overweight $135 → $140
Aug-21-23Reiterated Mizuho Neutral $112 → $113
Jul-24-23Upgrade SVB Securities Market Perform → Outperform $115 → $125
Jul-06-23Upgrade BMO Capital Markets Underperform → Market Perform $91 → $96
May-04-23Upgrade Guggenheim Neutral → Buy $145
Mar-30-23Upgrade Canaccord Genuity Hold → Buy $124 → $132
Mar-03-23Upgrade Evercore ISI In-line → Outperform $130
May-16-24 04:47PM
May-14-24 08:30AM
May-09-24 11:51AM
11:51AM
09:45AM
08:30AM Loading…
08:30AM
02:35AM
May-08-24 08:30AM
May-07-24 04:15PM
08:30AM
May-06-24 08:30AM
May-04-24 08:00AM
May-03-24 01:15PM
May-02-24 11:18AM
03:01AM
01:06AM Loading…
01:06AM
May-01-24 11:36PM
09:01PM
04:18PM
11:54AM
09:30AM
09:04AM
08:31AM
08:15AM
07:18AM
07:00AM
Apr-30-24 05:48PM
05:45PM
05:31PM
05:12PM
09:15AM Loading…
09:15AM
Apr-24-24 10:15AM
10:01AM
08:30AM
08:00AM
Apr-23-24 11:50AM
07:22AM
07:00AM
Apr-22-24 11:10AM
Apr-16-24 04:01PM
02:30AM
Apr-10-24 04:01PM
Apr-09-24 07:37AM
Apr-03-24 08:30AM
Mar-28-24 08:30AM
Mar-24-24 09:19AM
Mar-23-24 08:00AM
Mar-16-24 08:00AM
01:23AM
01:23AM
Mar-15-24 10:00AM
Mar-13-24 01:26AM
Mar-11-24 04:01PM
01:12PM
Mar-06-24 04:45PM
Mar-01-24 12:40AM
Feb-27-24 04:01PM
Feb-22-24 11:28PM
03:55AM
Feb-15-24 11:36PM
Feb-10-24 10:18AM
12:14AM
Feb-09-24 02:23AM
Feb-08-24 09:13AM
12:20AM
Feb-07-24 09:30AM
07:33AM
07:18AM
07:00AM
Feb-05-24 09:16AM
Feb-02-24 11:02PM
Jan-31-24 10:00AM
Jan-24-24 11:02PM
06:54AM
Jan-22-24 09:38AM
Jan-17-24 04:16PM
Jan-12-24 09:35AM
Jan-11-24 09:02PM
Jan-10-24 09:24AM
Jan-05-24 02:02AM
Jan-02-24 04:01PM
Dec-26-23 06:56PM
07:22AM
Dec-25-23 08:23PM
Dec-20-23 04:54AM
Dec-16-23 01:01PM
Dec-15-23 02:30PM
Dec-12-23 03:05PM
Dec-10-23 11:15AM
Dec-09-23 11:05AM
Dec-06-23 03:01AM
Dec-05-23 04:01PM
Dec-02-23 05:06AM
Dec-01-23 07:00AM
Nov-30-23 05:04AM
Nov-13-23 06:07PM
07:00AM
Nov-09-23 04:01PM
Nov-08-23 04:05PM
04:01PM
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ABERNETHY MATTChief Financial OfficerMay 15 '24Option Exercise73.6015,0001,104,00046,528May 16 04:40 PM
ABERNETHY MATTChief Financial OfficerMay 15 '24Sale140.2415,0002,103,60931,528May 16 04:40 PM
ABERNETHY MATTChief Financial OfficerMay 14 '24Option Exercise73.6015,0001,104,00046,528May 16 04:40 PM
LYONS GARY ADirectorMay 14 '24Option Exercise42.7612,500534,500129,447May 16 04:55 PM
ABERNETHY MATTChief Financial OfficerMay 14 '24Sale135.6615,0002,034,82631,528May 16 04:40 PM
LYONS GARY ADirectorMay 14 '24Sale135.6312,5001,695,370116,947May 16 04:55 PM
Delaet IngridChief Regulatory OfficerMay 06 '24Option Exercise79.0227321,5727,780May 08 04:26 PM
Delaet IngridChief Regulatory OfficerMay 06 '24Sale140.5527338,3707,507May 08 04:26 PM
BENEVICH ERICChief Commercial OfficerApr 15 '24Option Exercise81.2119,8181,609,43153,365Apr 17 05:19 PM
BENEVICH ERICChief Commercial OfficerApr 15 '24Sale133.3619,8182,643,02040,778Apr 17 05:19 PM
Delaet IngridChief Regulatory OfficerApr 01 '24Option Exercise79.0227221,4937,779Apr 03 04:44 PM
Delaet IngridChief Regulatory OfficerApr 01 '24Sale137.3027237,3467,507Apr 03 04:44 PM
Delaet IngridChief Regulatory OfficerMar 21 '24Option Exercise103.525,000517,60012,507Mar 25 06:02 PM
Delaet IngridChief Regulatory OfficerMar 21 '24Sale145.065,000725,3207,507Mar 25 06:02 PM
BENEVICH ERICChief Commercial OfficerMar 14 '24Option Exercise80.9075,0006,067,628110,299Mar 15 05:33 PM
MORROW GEORGE JDirectorMar 14 '24Option Exercise39.7940,0001,591,60020,000Mar 15 05:25 PM
BENEVICH ERICChief Commercial OfficerMar 14 '24Sale139.3875,00010,453,41740,778Mar 15 05:33 PM
MORROW GEORGE JDirectorMar 14 '24Sale139.4240,0005,576,7100Mar 15 05:25 PM
POPS RICHARD FDirectorMar 13 '24Option Exercise42.7623,200992,03252,712Mar 15 05:19 PM
Delaet IngridChief Regulatory OfficerMar 13 '24Option Exercise106.023,000318,06010,507Mar 15 05:15 PM
POPS RICHARD FDirectorMar 13 '24Sale140.3323,2003,255,62129,512Mar 15 05:19 PM
Delaet IngridChief Regulatory OfficerMar 13 '24Sale140.143,000420,4197,507Mar 15 05:15 PM
Delaet IngridChief Regulatory OfficerMar 11 '24Option Exercise106.0220021,2047,707Mar 12 06:38 PM
POPS RICHARD FDirectorMar 11 '24Option Exercise42.761004,27629,612Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 11 '24Sale140.0020028,0007,507Mar 12 06:38 PM
POPS RICHARD FDirectorMar 11 '24Sale140.0010014,00029,512Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 08 '24Option Exercise106.021,800190,8369,307Mar 12 06:38 PM
POPS RICHARD FDirectorMar 08 '24Option Exercise42.761,70072,69231,212Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 08 '24Sale140.031,800252,0537,507Mar 12 06:38 PM
POPS RICHARD FDirectorMar 08 '24Sale140.051,700238,07829,512Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerFeb 29 '24Option Exercise79.0227321,5727,780Feb 29 07:02 PM
Delaet IngridChief Regulatory OfficerFeb 29 '24Sale135.5127336,9947,507Feb 29 07:02 PM
BENEVICH ERICChief Commercial OfficerFeb 28 '24Option Exercise53.6775,0004,025,04393,759Feb 29 06:55 PM
Delaet IngridChief Regulatory OfficerFeb 28 '24Option Exercise79.026,544517,10710,007Feb 29 07:02 PM
BENEVICH ERICChief Commercial OfficerFeb 28 '24Sale134.6975,00010,101,60840,616Feb 29 06:55 PM
Delaet IngridChief Regulatory OfficerFeb 28 '24Sale135.346,544885,6387,507Feb 29 07:02 PM
Norwalk Leslie VDirectorFeb 27 '24Option Exercise84.958,000679,6008,000Feb 29 06:50 PM
Norwalk Leslie VDirectorFeb 27 '24Sale135.678,0001,085,3880Feb 29 06:50 PM
POPS RICHARD FDirectorFeb 20 '24Option Exercise12.9815,000194,70044,512Feb 22 05:11 PM
POPS RICHARD FDirectorFeb 20 '24Sale132.4715,0001,987,04729,512Feb 22 05:11 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 13 '24Option Exercise39.285,090199,951512,052Feb 14 05:17 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 13 '24Sale133.022,832376,700514,596Feb 15 05:43 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 13 '24Sale133.071,811240,9964,895Feb 15 05:33 PM
Onyia JudeChief Scientific OfficerFeb 13 '24Sale132.941,432190,37113,128Feb 15 05:48 PM
Gano KyleChief Business Development OffFeb 13 '24Sale132.891,352179,674135,166Feb 15 05:40 PM
ABERNETHY MATTChief Financial OfficerFeb 13 '24Sale132.851,352179,61231,528Feb 15 05:27 PM
ROBERTS EIRYChief Medical OfficerFeb 13 '24Sale132.961,114148,12223,716Feb 15 05:51 PM
BENEVICH ERICChief Commercial OfficerFeb 13 '24Sale133.011,098146,05040,616Feb 15 05:29 PM
Lippoldt DarinChief Legal OfficerFeb 13 '24Sale132.991,098146,02839,740Feb 15 05:45 PM
Cooke JulieChief Human Resources OfficerFeb 13 '24Sale133.04796105,90217,976Feb 15 05:35 PM
Delaet IngridChief Regulatory OfficerFeb 13 '24Sale133.0371695,2537,507Feb 15 05:38 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 08 '24Sale134.152,274305,052506,962Feb 08 07:21 PM
Cooke JulieChief Human Resources OfficerFeb 08 '24Sale135.441,329179,99517,263Feb 08 07:35 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 08 '24Sale135.411,328179,8304,895Feb 08 07:46 PM
ABERNETHY MATTChief Financial OfficerFeb 08 '24Sale134.21980131,52930,314Feb 08 07:12 PM
ROBERTS EIRYChief Medical OfficerFeb 08 '24Sale134.21980131,52222,717Feb 08 07:28 PM
Gano KyleChief Business Development OffFeb 08 '24Sale134.20980131,519133,952Feb 08 07:17 PM
BENEVICH ERICChief Commercial OfficerFeb 08 '24Sale134.19980131,50939,631Feb 08 07:15 PM
Lippoldt DarinChief Legal OfficerFeb 08 '24Sale134.24911122,28938,755Feb 08 07:25 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 06 '24Sale142.183,040432,218504,919Feb 08 07:21 PM
Gano KyleChief Business Development OffFeb 06 '24Sale142.201,600227,522133,072Feb 08 07:17 PM
ABERNETHY MATTChief Financial OfficerFeb 06 '24Sale142.191,280182,00029,434Feb 08 07:12 PM
BENEVICH ERICChief Commercial OfficerFeb 06 '24Sale142.121,280181,91038,751Feb 08 07:15 PM
Cooke JulieChief Human Resources OfficerFeb 06 '24Sale142.071,215172,61717,263Feb 08 07:35 PM
ROBERTS EIRYChief Medical OfficerFeb 06 '24Sale142.241,121159,44621,837Feb 08 07:28 PM
Lippoldt DarinChief Legal OfficerFeb 06 '24Sale142.171,041147,99537,939Feb 08 07:25 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 06 '24Sale141.9645664,7344,894Feb 08 07:46 PM
Delaet IngridChief Regulatory OfficerFeb 01 '24Sale139.7762387,0776,865Feb 02 07:14 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 31 '24Sale140.692,707380,845502,188Feb 02 07:21 PM
Boyer David W.Chief Corp. Affairs OfficerJan 31 '24Sale140.802,096295,1154,894Feb 02 07:07 PM
Cooke JulieChief Human Resources OfficerJan 31 '24Sale141.291,740245,84217,263Feb 02 07:11 PM
Gano KyleChief Business Development OffJan 31 '24Sale140.701,541216,813131,635Feb 02 07:17 PM
ROBERTS EIRYChief Medical OfficerJan 31 '24Sale140.791,457205,13220,832Feb 02 07:29 PM
ABERNETHY MATTChief Financial OfficerJan 31 '24Sale140.721,283180,53928,284Feb 02 07:00 PM
Lippoldt DarinChief Legal OfficerJan 31 '24Sale140.651,250175,81037,005Feb 02 07:24 PM
BENEVICH ERICChief Commercial OfficerJan 31 '24Sale140.781,207169,92737,601Feb 02 07:05 PM
Delaet IngridChief Regulatory OfficerJan 31 '24Sale141.9442259,8996,309Feb 02 07:14 PM
Onyia JudeChief Scientific OfficerJan 31 '24Sale141.9412617,88411,843Feb 02 07:26 PM
Lippoldt DarinChief Legal OfficerJan 22 '24Option Exercise79.0210,000790,20045,882Jan 24 05:47 PM
Lippoldt DarinChief Legal OfficerJan 22 '24Sale139.8610,0001,398,55335,882Jan 24 05:47 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 09 '24Option Exercise19.5962,0231,215,031561,777Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 09 '24Sale134.0162,0238,311,895499,754Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 08 '24Option Exercise19.59105,8352,073,308605,589Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 08 '24Sale132.44105,83514,016,523499,754Jan 10 04:31 PM
Gano KyleChief Business Development OffJan 02 '24Option Exercise19.5975,0001,469,250199,134Jan 04 06:32 PM
RASTETTER WILLIAM HDirectorJan 02 '24Option Exercise12.9820,000259,60062,785Jan 04 06:26 PM
Gano KyleChief Business Development OffJan 02 '24Sale131.4775,0009,860,194130,250Jan 04 06:32 PM
RASTETTER WILLIAM HDirectorJan 02 '24Sale131.4711,0441,451,92751,741Jan 04 06:26 PM
Cooke JulieChief Human Resources OfficerDec 22 '23Option Exercise73.0424,0001,752,90031,263Dec 27 04:08 PM
Cooke JulieChief Human Resources OfficerDec 22 '23Sale128.6624,0003,087,80817,263Dec 27 04:08 PM
LYONS GARY ADirectorDec 22 '23Sale130.0410,0001,300,443193,697Dec 27 04:10 PM
ROBERTS EIRYChief Medical OfficerDec 22 '23Sale126.7410,0001,267,44819,521Dec 27 04:15 PM
ROBERTS EIRYChief Medical OfficerDec 12 '23Option Exercise81.0513,9251,128,62136,499Dec 14 05:22 PM
ROBERTS EIRYChief Medical OfficerDec 12 '23Sale120.3013,9251,675,24029,521Dec 14 05:22 PM
ROBERTS EIRYChief Medical OfficerDec 08 '23Option Exercise81.0530024,31529,721Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 08 '23Sale120.1030036,03129,521Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 07 '23Option Exercise78.5277,3796,076,12068,243Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 07 '23Sale120.3777,3799,314,31929,521Dec 11 06:18 PM
Lippoldt DarinChief Legal OfficerDec 06 '23Option Exercise43.2420,830900,68956,712Dec 08 06:23 PM
ROBERTS EIRYChief Medical OfficerDec 06 '23Option Exercise77.818,396653,29337,917Dec 08 07:09 PM
Last Close
May 17 04:00PM ET
23.03
Dollar change
+0.57
Percentage change
2.54
%
XNCR Xencor Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-2.19 Insider Own2.60% Shs Outstand61.00M Perf Week2.45%
Market Cap1.42B Forward P/E- EPS next Y-2.83 Insider Trans-8.61% Shs Float60.06M Perf Month21.53%
Income-133.36M PEG- EPS next Q-0.82 Inst Own104.17% Short Float11.12% Perf Quarter-4.64%
Sales162.18M P/S8.76 EPS this Y-71.19% Inst Trans-2.45% Short Ratio9.11 Perf Half Y21.72%
Book/sh9.94 P/B2.32 EPS next Y20.43% ROA-15.80% Short Interest6.68M Perf Year-13.13%
Cash/sh8.69 P/C2.65 EPS next 5Y- ROE-20.58% 52W Range16.49 - 28.96 Perf YTD8.48%
Dividend Est.- P/FCF26.96 EPS past 5Y-9.81% ROI-19.28% 52W High-20.48% Beta0.81
Dividend TTM- Quick Ratio7.08 Sales past 5Y70.11% Gross Margin92.42% 52W Low39.66% ATR (14)1.32
Dividend Ex-Date- Current Ratio7.08 EPS Y/Y TTM6.15% Oper. Margin-83.70% RSI (14)56.74 Volatility7.16% 6.44%
Employees280 Debt/Eq0.15 Sales Y/Y TTM65.41% Profit Margin-82.23% Recom1.50 Target Price34.64
Option/ShortYes / Yes LT Debt/Eq0.13 EPS Q/Q-9.33% Payout- Rel Volume0.90 Prev Close22.46
Sales Surprise-44.50% EPS Surprise-33.77% Sales Q/Q-32.47% EarningsMay 09 AMC Avg Volume732.88K Price23.03
SMA206.98% SMA506.31% SMA20010.72% Trades Volume658,302 Change2.54%
Date Action Analyst Rating Change Price Target Change
Apr-16-24Reiterated BTIG Research Buy $56 → $38
Feb-28-24Downgrade Piper Sandler Overweight → Neutral $37 → $24
May-19-23Initiated BofA Securities Buy $42
Dec-06-22Initiated Cowen Outperform
Oct-13-22Upgrade Raymond James Outperform → Strong Buy $58
Sep-21-22Initiated JP Morgan Overweight $37
Jul-06-22Resumed Canaccord Genuity Buy $50
Feb-11-22Initiated BMO Capital Markets Outperform $54
Jan-21-22Initiated SMBC Nikko Outperform $60
Dec-15-21Initiated H.C. Wainwright Buy $61
May-10-24 01:45PM
06:20AM
May-09-24 11:54PM
05:18PM
04:09PM
10:00AM Loading…
May-06-24 10:00AM
May-03-24 07:01PM
May-02-24 03:31AM
Apr-09-24 08:01AM
Mar-08-24 05:01PM
Mar-07-24 05:00PM
Feb-28-24 04:01PM
09:35AM
08:38AM
Feb-27-24 05:20PM
04:39PM Loading…
04:39PM
04:26PM
04:01PM
Feb-20-24 04:31PM
Feb-19-24 03:37AM
Feb-15-24 10:00AM
Jan-03-24 04:01PM
09:55AM
Jan-02-24 08:01AM
Dec-30-23 05:02PM
Nov-21-23 04:01PM
Nov-09-23 02:19PM
Nov-08-23 05:21AM
Nov-07-23 04:39PM
04:01PM
04:01PM Loading…
04:01PM
Nov-03-23 12:01PM
Oct-31-23 04:01PM
12:00PM
Oct-26-23 08:01AM
Oct-17-23 04:21AM
Sep-27-23 09:01AM
Sep-19-23 04:01PM
Aug-08-23 06:01AM
Aug-07-23 04:02PM
Aug-03-23 05:15PM
04:13PM
04:01PM
Jul-27-23 08:01AM
Jul-03-23 08:38PM
Jun-21-23 08:00PM
Jun-18-23 10:00AM
May-30-23 06:01PM
May-09-23 01:49PM
May-08-23 05:15PM
04:08PM
04:01PM
May-01-23 04:01PM
Apr-26-23 08:00PM
08:01AM
Apr-17-23 01:31PM
Apr-09-23 01:19PM
Mar-14-23 04:31PM
02:56AM
Feb-28-23 05:10AM
Feb-25-23 07:17AM
Feb-23-23 05:25PM
04:01PM
Feb-20-23 10:00AM
Feb-16-23 04:01PM
Feb-07-23 04:01PM
Jan-26-23 02:33PM
Jan-09-23 08:01AM
Jan-05-23 06:30AM
Jan-04-23 04:01PM
Dec-12-22 03:44PM
10:00AM
Nov-30-22 09:55AM
Nov-25-22 12:00PM
Nov-10-22 04:01PM
09:55AM
09:01AM
Nov-07-22 05:25PM
04:01PM
04:01PM
Nov-03-22 09:01AM
Oct-31-22 04:01PM
Oct-28-22 11:58AM
Oct-14-22 09:41AM
Oct-06-22 08:37PM
Oct-05-22 08:01AM
Sep-09-22 08:01AM
Aug-29-22 06:35AM
Aug-03-22 05:25PM
04:01PM
Aug-02-22 06:30AM
Aug-01-22 11:31AM
Jul-27-22 04:01PM
Jul-01-22 11:59AM
May-26-22 05:01PM
May-13-22 09:18AM
May-07-22 09:30AM
May-06-22 10:24AM
05:38AM
May-05-22 05:25PM
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Valente NancyEVP, Chief Development OfficerMay 02 '24Sale23.584,745111,87255,115May 03 04:06 PM
Dahiyat Bassil IPRESIDENT & CEOMar 11 '24Sale23.502,74164,418351,894Mar 12 04:03 PM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 11 '24Sale23.501,28030,082186,433Mar 12 04:05 PM
Eckert CeliaSVP, GENERAL COUNSELMar 11 '24Sale23.5085019,97745,465Mar 12 04:06 PM
Kuch John JSR. VICE PRESIDENT & CFOMar 11 '24Sale23.5084919,953121,070Mar 12 04:08 PM
GUSTAFSON KURT ADirectorMar 06 '24Option Exercise10.7315,000160,95020,007Mar 07 04:10 PM
GUSTAFSON KURT ADirectorMar 06 '24Sale23.1814,000324,4536,007Mar 07 04:10 PM
Dahiyat Bassil IPRESIDENT & CEOMar 05 '24Sale23.4312,528293,519300,097Mar 07 04:01 PM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 05 '24Sale23.436,629155,311166,989Mar 07 04:05 PM
Kuch John JSR. VICE PRESIDENT & CFOMar 05 '24Sale23.434,474104,821121,919Mar 07 04:07 PM
Eckert CeliaSVP, GENERAL COUNSELMar 05 '24Sale23.433,89291,18633,226Mar 07 04:03 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 14 '24Option Exercise11.0511,943131,970173,618Feb 16 04:06 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 13 '24Option Exercise11.0568,057752,030215,783Feb 14 02:23 PM
GORMAN KEVIN CHARLESDirectorFeb 13 '24Buy19.12531,0135,060Feb 15 04:02 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 13 '24Sale19.3854,1081,048,743161,675Feb 14 02:23 PM
Dahiyat Bassil IPRESIDENT & CEODec 29 '23Option Exercise11.0565,001718,261357,929Dec 29 04:24 PM
Dahiyat Bassil IPRESIDENT & CEODec 29 '23Sale20.9345,000941,670312,929Dec 29 04:24 PM
Dahiyat Bassil IPRESIDENT & CEOJun 21 '23Option Exercise4.2576,012323,051325,713Jun 22 08:33 AM
Dahiyat Bassil IPRESIDENT & CEOJun 21 '23Sale26.1933,497877,286292,216Jun 22 08:33 AM